PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules
PMA exerts an anti-leukemia effect in Ph<sup>+</sup> ALL by activating PKC δ and its downstream molecules, thereby demonstrating its potential as a therapeutic agent for Ph<sup>+</sup> ALL.
Authors
- Suotian Liu
- J. H. Zou (ORCID: https://orcid.org/0009-0001-2680-5267)
- Meng Gao (ORCID: https://orcid.org/0000-0001-8071-8079)
- Renren Zheng
- Dachuan Zeng
- Wei Wei (ORCID: https://orcid.org/0000-0003-1263-5620)
- Jie Tang (ORCID: https://orcid.org/0000-0001-6121-2400)
- Teng Wang (ORCID: https://orcid.org/0000-0002-4336-8687)
- Xu Wang (ORCID: https://orcid.org/0000-0002-9267-8278)
- Jing Hu
- Yan Du (ORCID: https://orcid.org/0000-0002-4174-6488)
- Jinfeng Tan (ORCID: https://orcid.org/0000-0002-9692-531X)
- Zhenglan Huang
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Children's Hospital of Chongqing Medical University (CN)
- Henan Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1186/s12935-025-04013-4
- Primary Topic
- Biochemical and Molecular Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chongqing Medical University
- Natural Science Foundation of Chongqing
- Xinxiang Medical University
- Centre Scientifique et Technique du Bâtiment